The United Laboratories International (HKG:3933) booked 2.09 billion yuan in attributable profit for 2025, down 23% from 3.29 billion yuan in 2024, according to a Hong Kong bourse filing Tuesday.
Shares of the bulk medicine company fell over 2% in morning trade Wednesday.
Earnings per share were 1.1065 yuan, compared with 1.4639 yuan in the prior year.
Revenue fell 4% year on year to 13.2 billion yuan, figures showed.
The company also proposed a final dividend of 0.26 yuan for the year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments